6 days ago · Bain Capital will partner with Milacron’s current owner, Hillenbrand, Inc. (NYSE: HI), who will remain a significant investor in the business to accelerate the Company’s continued growth. Bain Capital entered into a definitive agreement to purchase an ownership stake of approximately 51% of Milacron for $287 million, subject to customary ...

5 days ago · Bain Capital entered into a definitive agreement to purchase an ownership stake of approximately 51% of Milacron for $287 million, subject to customary closing adjustments. Hillenbrand will retain ...

4 days ago · Bain Capital announced it has made a majority investment in the Milacron injection molding and extrusion business. Bain Capital has reached a definitive agreement to acquire approximately 51% of Milacron for $287 million, subject to customary closing adjustments.

5 days ago · Batesville, Ind.-based Hillenbrand Inc. is selling the majority of its Milacron injection molding and extrusion business to an affiliate of Bain Capital for $287 million.

5 days ago · Milacron is an injection molding and extrusion business. Photo: Lubos Pavlicek/Zuma Press Hillenbrand has sold a majority stake in Milacron to an affiliate of Bain Capital Special Situations.

5 days ago · On February 5, the company entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection molding and extrusion business to an affiliate of Bain ...

20 hours ago · Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron business to Bain Capital, a leading private investment firm. The transaction, valued at $287 million, is expected to close in the coming months, subject to customary closing conditions. Hillenbrand will retain a 49 percent ownership stake in Milacron, ensuring continued involvement in the company's future growth and ...

4 days ago · Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery business to Bain Capital for $287 million.

5 days ago · Hillenbrand (NYSE: HI) reported fiscal Q1 2025 results and announced the sale of a majority stake in its Milacron injection molding business to Bain Capital for $287 million.Key financial highlights include: - Revenue decreased 9% to $707 million - GAAP EPS fell from $0.24 to $0.09 - Adjusted EPS declined 19% to $0.56

Bain Capital will partner with Milacron’s current owner, Hillenbrand, who will remain a significant investor in the business and accelerate the company’s continued growth. Bain Capital had entered into a definitive agreement to buy an ownership stake of approximately 51% of Milacron for $287 million, subject to customary closing adjustments